Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study

Leif Friberg, Mårten Rosenqvist, Gregory Y H Lip

Research output: Contribution to journalArticlepeer-review

348 Citations (Scopus)

Abstract

Known risk factors for bleeding during anticoagulant treatment are largely the same as those predicting thromboembolic events in patients with atrial fibrillation (AF). Our objective was to investigate how to maximize the likelihood of avoiding both stroke and bleeding.
Original languageEnglish
Pages (from-to)2298-2307
Number of pages10
JournalCirculation
Volume125
Issue number19
Early online date18 Apr 2012
DOIs
Publication statusPublished - 18 Apr 2012

Fingerprint

Dive into the research topics of 'Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study'. Together they form a unique fingerprint.

Cite this